ECHNO 2023 | The future role of immunotherapy in head and neck cancer

Paolo Bossi, MD, University of Brescia, Brescia, Italy, discusses the potential of immunotherapy (IO) for patients with head and neck cancer, including the investigation of new IO treatment combinations and the need to identify which patients will benefit most from receiving IO. This interview took place at the 2023 European Congress on Head and Neck Oncology (ECHNO) in Lisbon, Portugal.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.